These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1500354)

  • 1. Depudecin: a novel compound inducing the flat phenotype of NIH3T3 cells doubly transformed by ras- and src-oncogene, produced by Alternaria brassicicola.
    Matsumoto M; Matsutani S; Sugita K; Yoshida H; Hayashi F; Terui Y; Nakai H; Uotani N; Kawamura Y; Matsumoto K
    J Antibiot (Tokyo); 1992 Jun; 45(6):879-85. PubMed ID: 1500354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel compound, depudecin, induces production of transformation to the flat phenotype of NIH3T3 cells transformed by ras-oncogene.
    Sugita K; Yoshida H; Matsumoto M; Matsutani S
    Biochem Biophys Res Commun; 1992 Jan; 182(1):379-87. PubMed ID: 1731795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and cellular characterization of the detransformation agent, (-)-depudecin.
    Shimada J; Kwon HJ; Sawamura M; Schreiber SL
    Chem Biol; 1995 Aug; 2(8):517-25. PubMed ID: 9383455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase.
    Kwon HJ; Owa T; Hassig CA; Shimada J; Schreiber SL
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3356-61. PubMed ID: 9520369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolite diversity in the plant pathogen Alternaria brassicicola: factors affecting production of brassicicolin A, depudecin, phomapyrone A and other metabolites.
    Pedras MS; Park MR
    Mycologia; 2015; 107(6):1138-50. PubMed ID: 26297782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplasmodial compounds from the wood-decayed fungus Xylaria sp. BCC 1067.
    Isaka M; Jaturapat A; Kladwang W; Punya J; Lertwerawat Y; Tanticharoen M; Thebtaranonth Y
    Planta Med; 2000 Jun; 66(5):473-5. PubMed ID: 10909272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthesis and role in virulence of the histone deacetylase inhibitor depudecin from Alternaria brassicicola.
    Wight WD; Kim KH; Lawrence CB; Walton JD
    Mol Plant Microbe Interact; 2009 Oct; 22(10):1258-67. PubMed ID: 19737099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective Total Synthesis of (-)-Depudecin.
    García-Ruiz C; Cheng-Sánchez I; Sarabia F
    Org Lett; 2015 Nov; 17(22):5558-61. PubMed ID: 26517569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthesis of depudecin, a metabolite of Nimbya scirpicola.
    Tanaka M; Fujimori T; Nabeta K
    Biosci Biotechnol Biochem; 2000 Feb; 64(2):244-7. PubMed ID: 10737176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depudecin, a microbial metabolite containing two epoxide groups, exhibits anti-angiogenic activity in vivo.
    Oikawa T; Onozawa C; Inose M; Sasaki M
    Biol Pharm Bull; 1995 Sep; 18(9):1305-7. PubMed ID: 8845831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-parasitic activity of depudecin on Neospora caninum via the inhibition of histone deacetylase.
    Kwon HJ; Kim JH; Kim M; Lee JK; Hwang WS; Kim DY
    Vet Parasitol; 2003 Mar; 112(4):269-76. PubMed ID: 12623206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dorrigocins: novel antifungal antibiotics that change the morphology of ras-transformed NIH/3T3 cells to that of normal cells. I. Taxonomy of the producing organism, fermentation and biological activity.
    Karwowski JP; Jackson M; Sunga G; Sheldon P; Poddig JB; Kohl WL; Kadam S
    J Antibiot (Tokyo); 1994 Aug; 47(8):862-9. PubMed ID: 7928671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Retention of Gene Functions in a Secondary Metabolite Cluster.
    Reynolds HT; Slot JC; Divon HH; Lysøe E; Proctor RH; Brown DW
    Mol Biol Evol; 2017 Aug; 34(8):2002-2015. PubMed ID: 28460114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depudecin makes a debut.
    Privalsky ML
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3335-7. PubMed ID: 9520362
    [No Abstract]   [Full Text] [Related]  

  • 15. Dorrigocins: novel antifungal antibiotics that change the morphology of ras-transformed NIH/3T3 cells to that of normal cells. II. Isolation and elucidation of structures.
    Hochlowski JE; Whittern DN; Hill P; McAlpine JB
    J Antibiot (Tokyo); 1994 Aug; 47(8):870-4. PubMed ID: 7928672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dorrigocins: novel antifungal antibiotics that change the morphology of ras-transformed NIH/3T3 cells to that of normal cells. III. Biological properties and mechanism of action.
    Kadam S; McAlpine JB
    J Antibiot (Tokyo); 1994 Aug; 47(8):875-80. PubMed ID: 7928673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glucocorticoids on oncogene transformed NIH3T3 cells.
    Matin A; Cheng KL; Suen TC; Hung MC
    Oncogene; 1990 Jan; 5(1):111-6. PubMed ID: 2181373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversion of the transformed phenotypes of v-H-ras NIH3T3 cells by flavonoids through attenuating the content of phosphotyrosine.
    Kuo ML; Lin JK; Huang TS; Yang NC
    Cancer Lett; 1994 Nov; 87(1):91-7. PubMed ID: 7525047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different metastatic potentials of ras- and src-transformed BALB/c 3T3 A31 variant cells.
    Tatsuka M; Ota T; Yamagishi N; Kashihara Y; Wada M; Matsuda N; Mitsui H; Seiki M; Odashima S
    Mol Carcinog; 1996 Apr; 15(4):300-8. PubMed ID: 8634088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases.
    Aguirre-Ghiso JA; Frankel P; Farias EF; Lu Z; Jiang H; Olsen A; Feig LA; de Kier Joffe EB; Foster DA
    Oncogene; 1999 Aug; 18(33):4718-25. PubMed ID: 10467419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.